Peer-Reviewed Publication DGIST (Daegu Gyeongbuk Institute of Science and Technology) □ The DGIST (President Kunwoo Lee) research team, led by professors Jaesok Yu and Jungho Hyun of the Department of Robotics and Mechatronics Engineering (with doctoral students Hyojin Seong and Jinhwan Jeong as lead authors), improved blood vessel observation technology using ultrasound. The team developed […]
Peer-Reviewed Publication DGIST (Daegu Gyeongbuk Institute of Science and Technology) □ DGIST (President Kunwoo Lee) announced that a joint research team led by Professors Jaesok Yu, Hoejoon Kim, and Sanghoon Lee of the Department of Robotics and Mechatronics Engineering has developed an ultrasound imaging technology capable of clearly visualizing blood vessels deep inside the human
Visualizing blood vessels in the human body in 3D without injections or radiation! Read More »
Peer-Reviewed Publication Research image: Fig. 1: Future perspectives view more Credit: Copyright © 2025 Zi-Zhan Li et al. Cancer remains one of the most critical global public health challenges, exerting profound social, economic, and clinical burdens while limiting gains in human life expectancy. Despite advances in surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy, treatment failure and
Triaptosis—an emerging paradigm in cancer therapeutics Read More »
Analysis shows CAR T immune-related adverse events are related to higher non-cancer mortality Reports and Proceedings University of Pennsylvania School of Medicine ORLANDO – Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, are associated with high rates of death
by Sanjukta Mondal, Medical Xpress edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Semaglutide significantly improved glycemic control and weight outcomes in individuals with schizophrenia spectrum disorders. Credit: pxhere.com/en/photo/1375343 Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with schizophrenia spectrum disorders, according to a study published in JAMA
Ozempic can reduce metabolic risks in schizophrenia patients, multicenter study finds Read More »
by Université catholique de Louvain edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine (TMA). Published in Nature Metabolism, the study reveals that TMA, produced by gut bacteria from dietary choline, can
by Marianne Lie Becker, University of Southern Denmark edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain Gynecological disorders such as endometriosis, PCOS, and menstrual irregularities are common and often associated with pain and disruption to everyday life. They are typically diagnosed late, and many women experience both physical discomfort and mental distress
Depression more common among women with gynecological disorders, study finds Read More »
by American Society of Hematology edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: CC0 Public Domain According to a new trial, patients with chronic lymphocytic leukemia (CLL) show comparable outcomes whether they receive a single-agent treatment indefinitely or a combination treatment for a fixed period of time. This study was presented at the 67th ASH Annual
by American Society of Hematology edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable residual disease (MRD), may provide an early and reliable indicator of long-term outcomes for patients with acute myeloid leukemia (AML), according to
by American Society of Hematology edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Pixabay/CC0 Public Domain Nearly a third of families with children receiving chemotherapy for acute lymphoblastic leukemia (ALL)—the most common pediatric cancer—develop serious financial difficulties during their child’s treatment, including losing 25% or more of their household income and struggling to cover the
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866